WG
ARNA

Winton Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Winton Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,637
Closed -$1.17M – 1202
2021
Q4 		$1.17M Sell
12,637
-7,430
-37% -$490K 0.07% 405
2021
Q3 		$1.2M Sell
20,067
-4,519
-18% -$267K 0.07% 411
2021
Q2 		$1.68M Buy
24,586
+4,338
+21% +$283K 0.09% 254
2021
Q1 		$1.41M Buy
20,248
+269
+1% +$20.7K 0.08% 282
2020
Q4 		$1.53M Sell
19,979
-37,529
-65% -$2.81M 0.11% 200
2020
Q3 		$4.3M Sell
57,508
-55,300
-49% -$3.69M 0.14% 173
2020
Q2 		$7.1M Buy
112,808
+33,650
+43% +$1.85M 0.18% 105
2020
Q1 		$3.33M Sell
79,158
-65,807
-45% -$3.02M 0.09% 404
2019
Q4 		$6.58M Buy
144,965
+120,597
+495% +$5.7M 0.09% 376
2019
Q3 		$1.11M Buy
24,368
+8,542
+54% +$480K 0.01% 784
2019
Q2 		$928K Buy
15,826
+10,937
+224% +$565K 0.02% 431
2019
Q1 		$219K Buy
+4,889
New +$224K ﹤0.01% 934

Winton Group's ARNA Position: Q1 2022 in Review

Winton Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 12,637 shares — an estimated $1.17M sold.

Winton Group first reported a position in ARNA in Q1 2019 and held it in 12 quarters. The position peaked at $7.1M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Winton Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Winton Group sold 12,637 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.17M.
  • Winton Group first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 12 quarters.
  • Winton Group's Arena Pharmaceuticals Inc position peaked at $7.1M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Winton Group's 13F filing for Q1 2022, filed 11 May 2022.